𝔖 Bobbio Scriptorium
✦   LIBER   ✦

How chronic pain patients cope with pain: Relation to treatment outcome in a multidisciplinary pain clinic

✍ Scribed by Chris L. Kleinke


Publisher
Springer US
Year
1992
Tongue
English
Weight
920 KB
Volume
16
Category
Article
ISSN
0147-5916

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Depression and age as predictors of pati
✍ A.B. Bremander; G. HolmstrΓΆm; S. Bergman πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 253 KB

## Abstract Background. The recommended treatment for chronic musculoskeletal pain is multidisciplinary, with a cognitive approach. The aim of this study was to investigate health‐related quality of life (HRQoL) outcome after a multidisciplinary treatment with a cognitive approach. Methods. A tota

Clinical and functional outcomes in pati
✍ David V. Sheehan; Pratap R. Chokka; Renee E. Granger; Richard J. Walton; Joel Ra πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 339 KB πŸ‘ 1 views

## Objective This post hoc analysis of a multicenter, single‐arm, open‐label trial (the Attributes of Response in Depressed Patients Switched to Treatment with Duloxetine [ARDENT] study) assessed the relationship between functional improvement in the Sheehan Disability Scale (SDS) and clinical outc

Radiological and scintigraphic findings
✍ Henk Simon Goei The; Albert J. Lemmens; Gerard Goedhard; Henri Lokkerbol; Ali Ra πŸ“‚ Article πŸ“… 1985 πŸ› Springer 🌐 English βš– 626 KB

The prevalence of radiological abnormalities of the sacroiliac joints, the manubriosternal joint, and the lumbar spine were assessed, and quantitative sacroiliac scintigraphy was performed in 151 patients with a history of chronic inflammatory back pain and in 31 controls with non-inflammatory back

Controlled-release morphine tablets in p
✍ Carol A. Warfield πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 143 KB πŸ‘ 2 views

## Background: Controlled-release (cr) morphine tablets have become routine therapy in the management of cancer pain. compared with immediate-release (ir) morphine, this formulation provides the benefit of dosing every 12 hours. ## Methods: This study reviewed the 10 published, well controlled, r